Ameritas Investment Partners, Inc. Blueprint Medicines Corp Transaction History

Ameritas Investment Partners, Inc.

$2.86 Billion
Q1 2024

A detailed history of Ameritas Investment Partners, Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 6,142 shares of BPMC stock, worth $661,984. This represents 0.02% of its overall portfolio holdings.

Number of Shares

6,142

Previous 6,142 -0.0%

Holding current value

$661,984

Previous $566,000 2.83%

% of portfolio

0.02%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$43.96 - $92.84 $4,396 - $9,284	100 Added 1.66%	6,142 $566,000
Q3 2023 Nov 13, 2023	BUY	$46.9 - $66.0 $47,838 - $67,320	1,020 Added 20.31%	6,042 $303,000
Q2 2023 Aug 11, 2023	BUY	$42.2 - $66.37 $10,128 - $15,928	240 Added 5.02%	5,022 $317,000
Q4 2022 Feb 13, 2023	BUY	$41.06 - $66.48 $8,458 - $13,694	206 Added 4.5%	4,782 $209,000
Q3 2021 Nov 15, 2021	SELL	$80.98 - $109.47 $4,049 - $5,473	-50 Reduced 1.08%	4,576 $470,000

Q2 2021 Aug 06, 2021	BUY	$82.78 - $101.0 $10,347 - $12,625	125 Added 2.78%	4,626 $407,000
Q1 2021 May 14, 2021	SELL	$90.71 - $108.28 $12,245 - $14,617	-135 Reduced 2.91%	4,501 $438,000
Q4 2020 Feb 12, 2021	SELL	$92.08 - $124.48 $14,456 - $19,543	-157 Reduced 3.28%	4,636 $520,000
Q2 2020 Aug 05, 2020	BUY	$57.09 - $79.27 $456 - $634	8 Added 0.17%	4,793 $374,000
Q1 2020 May 13, 2020	BUY	$48.11 - $82.22 $24,920 - $42,589	518 Added 12.14%	4,785 $280,000
Q4 2019 Feb 13, 2020	BUY	$66.73 - $82.59 $7,273 - $9,002	109 Added 2.62%	4,267 $342,000
Q2 2019 Aug 14, 2019	BUY	$73.54 - $97.8 $52,654 - $70,024	716 Added 20.8%	4,158 $392,000
Q2 2018 Aug 13, 2018	SELL	$60.96 - $101.18 $9,144 - $15,177	-150 Reduced 4.18%	3,442 $218,000
Q1 2018 May 15, 2018	SELL	$73.28 - $102.95 $7,254 - $10,192	-99 Reduced 2.68%	3,592 $329,000
Q4 2017 Feb 14, 2018	BUY	$62.91 - $88.32 $17,677 - $24,817	281 Added 8.24%	3,691 $278,000
Q2 2017 Aug 15, 2017	BUY	N/A	3,410	3,410 $173,000

Others Institutions Holding BPMC

# of Institutions

313

Shares Held

60.6M

Call Options Held

634K

Put Options Held

691K

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $6.44B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.

Account

Ameritas Investment Partners, Inc. Blueprint Medicines Corp Transaction History